Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Dermatologic Therapy|December 2, 2017
Styling without shedding: Novel topical formula reduces hair shedding by contracting the arrector pili muscleJohn McCoy, Andy Goren, Maja Kovacevic, et al.
Journal of Drugs in Dermatology : JDD|January 10, 2022
Treatment of Alopecia in ChildrenPranshu Mishra, Anant Patil, Rodney Sinclair, et al.
Clinical and Experimental Dermatology|July 26, 2022
Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?Shreya Singh, Anant Patil, Nika Kianfar, et al.
American Journal of Clinical Dermatology|October 23, 2024
Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical TrialRodney Sinclair, Natasha Mesinkovska, Debanjali Mitra, et al.
Journal of the American Academy of Dermatology|April 11, 2025
Summation and recommendations for the safe and effective use of topical and oral minoxidilElise A Olsen, Rodney Sinclair, Maria Hordinsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Epidermal Wnt/β-catenin signaling regulates adipocyte differentiation via secretion of adipogenic factorsGiacomo Donati, Valentina Proserpio, Beate Maria Lichtenberger, et al.
The Australasian Journal of Dermatology|May 20, 2024
Health-related quality of life of adult and adolescent patients living with alopecia areata in AustraliaRodney Sinclair, Samantha Eisman, Carol M Y Lee, et al.
The Journal of Investigative Dermatology|May 2, 2002
Evidence for pseudodominant inheritance of atrichia with papular lesionsAbraham Zlotogorski, Amalia Martinez-Mir, Jack Green, et al.
Journal of Cosmetic Dermatology|August 27, 2020
Novel "After Minoxidil" spray improves topical minoxidil compliance and hair style manageabilityMaja Kovacevic, John McCoy, Jerry Shapiro, et al.
Clinical and Translational Science|October 18, 2023
Rademikibart (CBP-201), a next-generation monoclonal antibody targeting human IL-4Rα: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitisJunying Wang, Jeffery White, Kenneth J Sansone, et al.
Pageof 17